查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597853

Tapentadol市场：按应用程式、最终用户划分 - 全球预测 2025-2030

Tapentadol Market by Application (Cough Treatment, Pain Management), End User (Clinic, Hospital, Pharmacy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Tapentadol市值为38.6亿美元，预计到2024年将达到41亿美元，预计复合年增长率为6.38%，到2030年将达到59.5亿美元。

Tapentadol是一种用于疼痛治疗的止痛药物，特别是用于治疗中度至重度急性疼痛，并占据医药​​市场的重要部分。其双重作用机制结合了鸦片受体激动和去甲肾上腺素再摄取抑制，可增强疼痛控制，且副作用可能比传统鸦片类药物更少。全球对阿片类药物滥用的担忧增加了对替代性疼痛管理解决方案的需求，这使得Tapentadol多成为医疗保健提供者的一个有吸引力的选择。Tapentadol主要用于医院、门诊和安宁疗护领域。Tapentadol的最终用途范围从急性术后疼痛管理到慢性疼痛，例如神经病变疼痛和癌症疼痛。慢性疼痛疾病盛行率上升、老年人口增加以及对高效、安全疼痛治疗方案的需求不断增加等因素正在影响市场的成长。此外，对疼痛管理疗法的监管支持以及正在进行的探索Tapentadol多其他潜在用途的临床试验也带来了重大机会。公司可以透过开发新型药物输送系统和研究联合治疗来利用这些优势，以提高疗效和患者依从性。然而，市场面临诸如对镇痛药严格的监管要求、潜在的依赖性以及来自传统阿片类药物和新型非阿片类镇痛药的竞争等限制。进一步的挑战包括关于阿片类药物使用和严格的医药品认证过程的持续争论。为了克服这些障碍，重点关注创新和研究领域，例如改进配方、防滥用特性和个人化医疗方法。该市场竞争激烈，但提供了重要的成长途径，因为利用数位健康平台和人工智慧驱动的疼痛管理解决方案等技术进步的公司可以获得竞争优势。了解这些动态对于努力提高市场地位并提供永续疼痛管理解决方案的公司至关重要。

主要市场统计
基准年[2023] 38.6亿美元
预测年份 [2024] 41亿美元
预测年份 [2030] 59.5亿美元
复合年增长率（%） 6.38%

市场动态：揭示快速发展的Tapentadol市场的关键市场洞察

Tapentadol市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性肌肉骨骼疼痛的高发生率
    • 对非处方止痛药的需求增加
    • 糖尿病盛行率上升，镇痛药需求增加
  • 市场限制因素
    • Tapentadol相关的副作用
  • 市场机会
    • 治疗和治疗开发的进展
    • 透过线上药局扩大供应
  • 市场问题
    • 严格的政府法规和替代品的可用性

波特的五力：驾驭他Tapentadol市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解Tapentadol市场的外部影响

外部宏观环境因素在塑造Tapentadol市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解Tapentadol市场的竞争格局

对Tapentadol市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：他Tapentadol市场供应商的绩效评估

FPNV 定位矩阵是评估Tapentadol市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製他Tapentadol市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，Tapentadol市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性肌肉骨骼疼痛的高发生率
      • 对非处方止痛药的需求增加
      • 糖尿病流行和对止痛药的需求不断增加
    • 抑制因素
      • Tapentadol相关的副作用
    • 机会
      • 治疗和治疗开发的进展
      • 透过网路药局获得更多可得性
    • 任务
      • 严格的政府法规和替代品的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章Tapentadol市场：按应用

  • 介绍
  • 咳嗽治疗
  • 疼痛管理
    • 癌症痛
    • 神经病变疼痛

第七章Tapentadol市场：依最终用户分类

  • 介绍
  • 诊所
  • 医院
  • 药局

第八章 美洲Tapentadol市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区Tapentadol市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲Tapentadol市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Apotex Corporation
  • Arene Life Sciences limited
  • Cadila Pharmaceuticals Ltd.
  • Curia Global, Inc.
  • Grunenthal GmbH
  • IPCA Laboratories Ltd.
  • Johnson & Johnson Services, Inc.
  • Lupin Laboratories Ltd.
  • Manus Aktteva Biopharma LLP
  • Physicians Total Care, Inc.
  • Quality Care Products
  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceutical Limited
  • Tirupati Medicare Ltd
  • Virupaksha Group
Product Code: MRR-43676CF42C2A

The Tapentadol Market was valued at USD 3.86 billion in 2023, expected to reach USD 4.10 billion in 2024, and is projected to grow at a CAGR of 6.38%, to USD 5.95 billion by 2030.

Tapentadol, an analgesic used for pain management, particularly in managing moderate to severe acute pain, represents a vital segment within the pharmaceutical market. Its dual-action mechanism combines opioid receptor agonism and norepinephrine reuptake inhibition, enhancing pain control with potentially fewer side effects than traditional opioids. The necessity for alternative pain management solutions is increasingly pressing due to global concerns over opioid misuse, making tapentadol an attractive option for healthcare providers. It is primarily used in hospital settings, outpatient clinics, and by the palliative care sector. The end-use scope of tapentadol spans from acute post-operative pain management to chronic pain conditions like neuropathic and cancer pain. Influencing the market growth are factors such as the rising prevalence of chronic pain conditions, a growing elderly population, and increased demand for efficient and safer pain management options. Additionally, regulatory support for pain management therapies and ongoing clinical trials exploring other potential applications of tapentadol present substantial opportunities. Companies can capitalize on these by developing novel drug delivery systems or investigating combination therapies to improve efficacy and patient compliance. Nevertheless, the market faces limitations such as stringent regulatory requirements for pain medications, potential for dependency, and competition from both traditional opioids and new non-opioid analgesics. Moreover, ongoing debates about opioid use and stringent drug approval processes pose challenges. To overcome these barriers, focusing on innovation and research areas like improved drug formulations, abuse-deterrent properties, and personalized medicine approaches could be crucial. The market is competitive yet offers significant avenues for growth as companies that leverage technological advancements, such as digital health platforms and AI-driven pain management solutions, can attain a competitive edge. Understanding these dynamics is essential for companies striving to enhance their market position and offer sustainable pain management solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 3.86 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 5.95 billion
CAGR (%) 6.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tapentadol Market

The Tapentadol Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High occurrence of chronic musculoskeletal pain
    • Rising demand for over-the-counter painkillers
    • Escalating prevalence of diabetes and increasing need for analgesics
  • Market Restraints
    • Side effects associated with tapentadol
  • Market Opportunities
    • Advancement in treatment and therapeutics development
    • Exponential availability through online pharmacies
  • Market Challenges
    • Strict government regulations and availability of substitute

Porter's Five Forces: A Strategic Tool for Navigating the Tapentadol Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tapentadol Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tapentadol Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tapentadol Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tapentadol Market

A detailed market share analysis in the Tapentadol Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tapentadol Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tapentadol Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tapentadol Market

A strategic analysis of the Tapentadol Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tapentadol Market, highlighting leading vendors and their innovative profiles. These include Apotex Corporation, Arene Life Sciences limited, Cadila Pharmaceuticals Ltd., Curia Global, Inc., Grunenthal GmbH, IPCA Laboratories Ltd., Johnson & Johnson Services, Inc., Lupin Laboratories Ltd., Manus Aktteva Biopharma LLP, Physicians Total Care, Inc., Quality Care Products, Sun Pharmaceutical Industries Limited, Taj Pharmaceutical Limited, Tirupati Medicare Ltd, and Virupaksha Group.

Market Segmentation & Coverage

This research report categorizes the Tapentadol Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Cough Treatment and Pain Management. The Pain Management is further studied across Cancer Pain and Neuropathic Pain.
  • Based on End User, market is studied across Clinic, Hospital, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High occurrence of chronic musculoskeletal pain
      • 5.1.1.2. Rising demand for over-the-counter painkillers
      • 5.1.1.3. Escalating prevalence of diabetes and increasing need for analgesics
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with tapentadol
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in treatment and therapeutics development
      • 5.1.3.2. Exponential availability through online pharmacies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations and availability of substitute
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tapentadol Market, by Application

  • 6.1. Introduction
  • 6.2. Cough Treatment
  • 6.3. Pain Management
    • 6.3.1. Cancer Pain
    • 6.3.2. Neuropathic Pain

7. Tapentadol Market, by End User

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital
  • 7.4. Pharmacy

8. Americas Tapentadol Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Tapentadol Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Tapentadol Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Corporation
  • 2. Arene Life Sciences limited
  • 3. Cadila Pharmaceuticals Ltd.
  • 4. Curia Global, Inc.
  • 5. Grunenthal GmbH
  • 6. IPCA Laboratories Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Lupin Laboratories Ltd.
  • 9. Manus Aktteva Biopharma LLP
  • 10. Physicians Total Care, Inc.
  • 11. Quality Care Products
  • 12. Sun Pharmaceutical Industries Limited
  • 13. Taj Pharmaceutical Limited
  • 14. Tirupati Medicare Ltd
  • 15. Virupaksha Group

LIST OF FIGURES

  • FIGURE 1. TAPENTADOL MARKET RESEARCH PROCESS
  • FIGURE 2. TAPENTADOL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TAPENTADOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TAPENTADOL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TAPENTADOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TAPENTADOL MARKET DYNAMICS
  • TABLE 7. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TAPENTADOL MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TAPENTADOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TAPENTADOL MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2023